• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Amgen Inc. (AMGN)

    -NasdaqGS
    152.26 Down 4.11(2.63%) 4:00PM EST
    |After Hours : 153.00 Up 0.74 (0.49%) 7:52PM EST
    Add to Portfolio
    Prev Close:156.37
    Open:155.55
    Bid:N/A
    Ask:156.87 x 100
    1y Target Est:174.14
    Beta:0.49
    Earnings Date:Apr 20 - Apr 24 (Est.)
    Day's Range:151.53 - 156.87
    52wk Range:108.20 - 173.14
    Volume:5,318,204
    Avg Vol (3m):3,567,220
    Market Cap:115.72B
    P/E (ttm):22.73
    EPS (ttm):6.70
    Div & Yield:3.16 (2.00%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AMGNDown 2.63%115.72B
    JNJDown 2.19%280.30B
    NVSDown 1.77%233.63B
    TEVADown 1.22%48.60B

    Key Statistics

    Forward P/E (1 yr):14.45
    P/S (ttm):5.92
    Ex-Dividend Date:10-Feb-15

    Analysts

    Annual EPS Est (Dec-15) :9.32
    Quarterly EPS Est (Mar-15) :2.12
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):1.47

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback